Literature DB >> 28899286

Restless legs syndrome related to hemorrhage of a thoracic spinal cord cavernoma.

Malik Hamdaoui1, Elisabeth Ruppert1,2,3, Henri Comtet1,2,3, Ulker Kilic-Huck1,2,3, Valérie Wolff3,4, Marc Bataillard1,2,3, Patrice Bourgin1,2,3.   

Abstract

CONTEXT: Restless legs syndrome (RLS) is a common neurological disorder characterized by an irresistible urge to move the lower limbs often accompanied by unpleasant sensations in the legs, worsened at rest and in the evening. Symptoms are improved by movement. Its pathophysiology remains poorly understood. Lesion-related RLS has been reported, mainly in cases of stroke-related RLS involving the brainstem and lenticulostriate nuclei. Only few data of RLS in a context of spinal cord injury have been reported.
FINDINGS: We report the case of a woman with secondary RLS due to hemorrhage of a spinal cord cavernoma located at T9-T10. Following recovery from the acute phase of the hemorrhage, the patient began to complain about restlessness in her legs causing impaired sleep and daytime somnolence. Polysomnographic investigations found a high index of periodic leg movements during sleep (71/hour), but no sleep disordered breathing. Iron stores were normal. Relief of symptom's severity was obtained with gabapentin 600mg in the evening. CONCLUSION/CLINICAL RELEVANCE: We hypothesize a possible involvement of the diencephalospinal pathway in the patient's RLS pathophysiology. A systematic study of focal lesions associated with RLS may contribute to improving our understanding of the pathophysiological mechanisms underlying this condition. The frequency of RLS associated with lesions of the spinal cord might be underestimated. Clinicians should be aware of spinal cord lesion-related RLS, especially as efficient treatments are available.

Entities:  

Keywords:  Lesion-associated RLS; Lesion-related PLM; Lesion-related RLS; Secondary restless legs syndrome; Willis-Ekbom disease

Mesh:

Substances:

Year:  2017        PMID: 28899286      PMCID: PMC5901462          DOI: 10.1080/10790268.2017.1368963

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  17 in total

1.  Restless leg syndrome in patients with spinal cord injury.

Authors:  Hatice Kumru; Joan Vidal; Jesus Benito; Manuela Barrio; Enric Portell; Margarita Valles; Cecilia Flores; Joan Santamaria
Journal:  Parkinsonism Relat Disord       Date:  2015-10-09       Impact factor: 4.891

2.  Restless legs syndrome as a first manifestation of a cerebral infarct.

Authors:  Elisabeth Ruppert; Ulker Kilic-Huck; Valérie Wolff; Laurent Tatu; Marion Ghobadi; Marc Bataillard; Patrice Bourgin
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

3.  Hyperdopaminergism in lenticulostriate stroke-related restless legs syndrome: an imaging study.

Authors:  Elisabeth Ruppert; Marc Bataillard; Izzie Jacques Namer; Laurent Tatu; Aurélien Hacquard; Laurence Hugueny; Jeffrey Hubbard; Ulker Kilic-Huck; Valérie Wolff; Patrice Bourgin
Journal:  Sleep Med       Date:  2016-03-22       Impact factor: 3.492

Review 4.  Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.

Authors:  Stefan Clemens; David Rye; Shawn Hochman
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

5.  Treatment-resistant sensory motor symptoms in persons with SCI may be signs of restless legs syndrome.

Authors:  S Nilsson; R Levi; A Nordström
Journal:  Spinal Cord       Date:  2010-11-30       Impact factor: 2.772

Review 6.  Epidemiology of restless legs syndrome: a synthesis of the literature.

Authors:  Maurice M Ohayon; Ruth O'Hara; Michael V Vitiello
Journal:  Sleep Med Rev       Date:  2011-07-26       Impact factor: 11.609

7.  Dopaminergic treatment of restless legs syndrome in spinal cord injury patients with neuropathic pain.

Authors:  Hatice Kumru; Sergiu Albu; Joan Vidal; Manuela Barrio; Joan Santamaria
Journal:  Spinal Cord Ser Cases       Date:  2016-08-18

8.  Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.

Authors:  Diego Garcia-Borreguero; Michael H Silber; John W Winkelman; Birgit Högl; Jacquelyn Bainbridge; Mark Buchfuhrer; Georgios Hadjigeorgiou; Yuichi Inoue; Mauro Manconi; Wolfgang Oertel; William Ondo; Juliane Winkelmann; Richard P Allen
Journal:  Sleep Med       Date:  2016-02-23       Impact factor: 3.492

9.  Sleep-related periodic leg movements (nocturnal myoclonus) due to spinal cord lesion.

Authors:  T Yokota; K Hirose; H Tanabe; H Tsukagoshi
Journal:  J Neurol Sci       Date:  1991-07       Impact factor: 3.181

Review 10.  Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).

Authors:  Christopher J Earley; James Connor; Diego Garcia-Borreguero; Peter Jenner; John Winkelman; Phyllis C Zee; Richard Allen
Journal:  Sleep Med       Date:  2014-06-16       Impact factor: 3.492

View more
  1 in total

1.  Prospective evaluation of sleep disturbances in chronic pancreatitis and its impact on quality of life: a pilot study.

Authors:  Awais Ahmed; Amit N Anand; Ishani Shah; William Yakah; Steven D Freedman; Robert Thomas; Sunil G Sheth
Journal:  Sleep Breath       Date:  2022-01-04       Impact factor: 2.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.